Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mRNA Vaccine”

370 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 370 results

Testing effectiveness (Phase 2)Study completedNCT05868382
What this trial is testing

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

Who this might be right for
Influenza
ModernaTX, Inc. 270
Testing effectiveness (Phase 2)Temporarily pausedNCT05672355
What this trial is testing

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaCOVID-19 Infection
City of Hope Medical Center 80
Early research (Phase 1)Study completedNCT05897190
What this trial is testing

Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster

Who this might be right for
SARS-CoV-2
Argorna Pharmaceuticals Co., LTD 60
Not applicableUnknownNCT05981066
What this trial is testing

A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Peking Union Medical College Hospital 48
Post-approval studies (Phase 4)Looking for participantsNCT06585241
What this trial is testing

Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 1,144
Testing effectiveness (Phase 2)Study completedNCT05373472
What this trial is testing

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

Who this might be right for
COVID-19
CanSino Biologics Inc. 150
Not applicableUnknownNCT05547256
What this trial is testing

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 54
Not applicableUnknownNCT04900467
What this trial is testing

Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine

Who this might be right for
Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
Assistance Publique - Hôpitaux de Paris 418
Not applicableStudy completedNCT05438472
What this trial is testing

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

Who this might be right for
Myocarditis
University Hospital, Basel, Switzerland 835
Testing effectiveness (Phase 2)UnknownNCT05027672
What this trial is testing

Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.

Who this might be right for
COVID-19 Vaccines
Ministerio de Salud de Ciudad Autónoma de Buenos Aires 348
Early research (Phase 1)Looking for participantsNCT07077356
What this trial is testing

Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 15
Early research (Phase 1)Study completedNCT03014089
What this trial is testing

Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects

Who this might be right for
Zika Virus
ModernaTX, Inc. 90
Not applicableStudy completedNCT05465863
What this trial is testing

Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases

Who this might be right for
Chronic Kidney Disease 5DChronic Kidney Disease 5T
Istanbul University - Cerrahpasa 101
Post-approval studies (Phase 4)Study completedNCT06065176
What this trial is testing

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

Who this might be right for
COVID-19Vaccine-Preventable DiseasesSARS CoV 2 Infection+2 more
Sarang K. Yoon, DO, MOH 1,188
Not applicableStudy completedNCT05359250
What this trial is testing

Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

Who this might be right for
Myocardial InjuryCOVID-19Vaccine Reaction
University of Colorado, Denver 10
Large-scale testing (Phase 3)Study completedNCT06354998
What this trial is testing

An Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 217
Testing effectiveness (Phase 2)WithdrawnNCT05254236
What this trial is testing

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd.
Testing effectiveness (Phase 2)Looking for participantsNCT07379580
What this trial is testing

Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Who this might be right for
Mpox (Monkeypox)SmallpoxOrthopoxvirus Infection
BioNTech SE 310
Early research (Phase 1)Study completedNCT04813796
What this trial is testing

Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 104
Large-scale testing (Phase 3)UnknownNCT05470803
What this trial is testing

An Observer-blind, Cohort Randomized, Exploratory Phase 3 Study to Evaluate the Safety and Immunogenicity of Recombinant Covid-19 Vaccine, mRNA Covid-19 Vaccine and Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine as 4th Dose in Individuals Primed/ Boosted With Various Regimens

Who this might be right for
COVID-19
D'Or Institute for Research and Education 360
Load More Results